A citation-based method for searching scientific literature

Etienne C Hirsch, Peter Jenner, Serge Przedborski. Mov Disord 2013
Times Cited: 175







List of co-cited articles
1073 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C Hirsch, Stéphane Hunot. Lancet Neurol 2009
18

Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
16


Staging of brain pathology related to sporadic Parkinson's disease.
Heiko Braak, Kelly Del Tredici, Udo Rüb, Rob A I de Vos, Ernst N H Jansen Steur, Eva Braak. Neurobiol Aging 2003
11

Pharmacological treatment of Parkinson disease: a review.
Barbara S Connolly, Anthony E Lang. JAMA 2014
780
11

Glial reactions in Parkinson's disease.
Patrick L McGeer, Edith G McGeer. Mov Disord 2008
515
11

A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.
Francesca L'episcopo, Maria F Serapide, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Stefano Pluchino, Bianca Marchetti. Mol Neurodegener 2011
151
10

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
10

Parkinson's disease: mechanisms and models.
William Dauer, Serge Przedborski. Neuron 2003
9

Understanding Dopaminergic Cell Death Pathways in Parkinson Disease.
Patrick P Michel, Etienne C Hirsch, Stéphane Hunot. Neuron 2016
314
9

Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.
Francesca L'Episcopo, Cataldo Tirolo, Salvo Caniglia, Nuccio Testa, Maria Concetta Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti. J Mol Cell Biol 2014
56
16


Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
F L'Episcopo, C Tirolo, N Testa, S Caniglia, M C Morale, C Cossetti, P D'Adamo, E Zardini, L Andreoni, A E C Ihekwaba,[...]. Neurobiol Dis 2011
143
9

Aging-induced Nrf2-ARE pathway disruption in the subventricular zone drives neurogenic impairment in parkinsonian mice via PI3K-Wnt/β-catenin dysregulation.
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria C Morale, Francesco Impagnatiello, Stefano Pluchino, Bianca Marchetti. J Neurosci 2013
71
12


The MPTP Story.
J William Langston. J Parkinsons Dis 2017
194
9

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
8

Epidemiology of Parkinson's disease.
Lonneke M L de Lau, Monique M B Breteler. Lancet Neurol 2006
8

Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.
Francesca L'episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Concetta Morale, Francesco Impagnatiello, Bianca Marchetti. Rejuvenation Res 2011
32
25

Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
Francesca L'Episcopo, Cataldo Tirolo, Nunzio Testa, Salvatore Caniglia, Maria Concetta Morale, Maria Francesca Serapide, Stefano Pluchino, Bianca Marchetti. Stem Cells 2014
80
10

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease.
Vanessa Brochard, Béhazine Combadière, Annick Prigent, Yasmina Laouar, Aline Perrin, Virginie Beray-Berthat, Olivia Bonduelle, Daniel Alvarez-Fischer, Jacques Callebert, Jean-Marie Launay,[...]. J Clin Invest 2009
735
8

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
M H Polymeropoulos, C Lavedan, E Leroy, S E Ide, A Dehejia, A Dutra, B Pike, H Root, J Rubenstein, R Boyer,[...]. Science 1997
8


Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
J A Obeso, M Stamelou, C G Goetz, W Poewe, A E Lang, D Weintraub, D Burn, G M Halliday, E Bezard, S Przedborski,[...]. Mov Disord 2017
376
8


Protocol for the MPTP mouse model of Parkinson's disease.
Vernice Jackson-Lewis, Serge Przedborski. Nat Protoc 2007
646
7

Stages in the development of Parkinson's disease-related pathology.
Heiko Braak, Estifanos Ghebremedhin, Udo Rüb, Hansjürgen Bratzke, Kelly Del Tredici. Cell Tissue Res 2004
7

Expanding insights of mitochondrial dysfunction in Parkinson's disease.
Patrick M Abou-Sleiman, Miratul M K Muqit, Nicholas W Wood. Nat Rev Neurosci 2006
646
7


Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.
Gaia Codolo, Nicoletta Plotegher, Tommaso Pozzobon, Marco Brucale, Isabella Tessari, Luigi Bubacco, Marina de Bernard. PLoS One 2013
355
7


Inflammation is genetically implicated in Parkinson's disease.
N Dzamko, C L Geczy, G M Halliday. Neuroscience 2015
147
7


Glia as a turning point in the therapeutic strategy of Parkinson's disease.
Francesca L' Episcopo, Cataldo Tirolo, Nuccio Testa, Salvo Caniglia, Maria Concetta Morale, Bianca Marchetti. CNS Neurol Disord Drug Targets 2010
53
13

Neurotoxic reactive astrocytes are induced by activated microglia.
Shane A Liddelow, Kevin A Guttenplan, Laura E Clarke, Frederick C Bennett, Christopher J Bohlen, Lucas Schirmer, Mariko L Bennett, Alexandra E Münch, Won-Suk Chung, Todd C Peterson,[...]. Nature 2017
7

Inflammation and Parkinson's disease pathogenesis.
Serge Przedborski. Mov Disord 2010
69
10

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
Anthony H V Schapira, C Warren Olanow, J Timothy Greenamyre, Erwan Bezard. Lancet 2014
260
7

Alpha-synuclein in Lewy bodies.
M G Spillantini, M L Schmidt, V M Lee, J Q Trojanowski, R Jakes, M Goedert. Nature 1997
7

Genetic and environmental factors in the cause of Parkinson's disease.
Thomas T Warner, Anthony H V Schapira. Ann Neurol 2003
265
7

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.
E R Dorsey, R Constantinescu, J P Thompson, K M Biglan, R G Holloway, K Kieburtz, F J Marshall, B M Ravina, G Schifitto, A Siderowf,[...]. Neurology 2007
7

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
6

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.
L F Lin, D H Doherty, J D Lile, S Bektesh, F Collins. Science 1993
6

Therapeutic prospects for Parkinson disease.
C Warren Olanow, Anthony H V Schapira. Ann Neurol 2013
96
6

The importance of Wnt signalling for neurodegeneration in Parkinson's disease.
Daniel C Berwick, Kirsten Harvey. Biochem Soc Trans 2012
98
6

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
T Kitada, S Asakawa, N Hattori, H Matsumine, Y Yamamura, S Minoshima, M Yokochi, Y Mizuno, N Shimizu. Nature 1998
6


The function of α-synuclein.
Jacob T Bendor, Todd P Logan, Robert H Edwards. Neuron 2013
472
6

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi,[...]. Ann Neurol 2011
169
6

Wnt your brain be inflamed? Yes, it Wnt!
Bianca Marchetti, Stefano Pluchino. Trends Mol Med 2013
124
6

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.
Hui-Ming Gao, Feng Zhang, Hui Zhou, Wayneho Kam, Belinda Wilson, Jau-Shyong Hong. Environ Health Perspect 2011
215
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.